Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
3,142,571
-
Share change
-
+3,142,571
-
Total reported value
-
$31,331,000
-
Price per share
-
$9.97
-
Number of holders
-
13
-
Value change
-
+$31,331,000
-
Number of buys
-
13
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2017
As of 30 Sep 2017 Krystal Biotech, Inc. - COMMON STOCK (KRYS) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,142,571 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., SABBY MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and TWO SIGMA SECURITIES, LLC.
This table shows 13 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.